Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Financing channel feed
Vaccine patch startup collects an additional $16M to Series A
3 months ago
Manufacturing
Lykos upheaval continues with four new board exits amid hunt for cash
3 months ago
People
Umoja’s $100M Series C will advance its bid for more convenient cell therapies
3 months ago
Cell/Gene Tx
Health tech funding in 2025 kicks off with megarounds
3 months ago
Health Tech
Normunity nabs $75M Series B to advance T cell engager and launch first trial
3 months ago
Startups
Aragen gets $100M from private equity firm to expand manufacturing footprint
3 months ago
Manufacturing
Exclusive: Bucking gene editing downturn, Tune raises $175M to bring epigenetic editing to clinic
3 months ago
Cell/Gene Tx
Chasing the next wave of obesity drugs, Metsera files for an IPO
4 months ago
Startups
Lilly finances new $500M biotech fund managed by a16z
4 months ago
Pharma
Exclusive: Moderna's former top scientist has a new startup using AI to improve mRNA therapies
4 months ago
Startups
Four biotechs emerge with $800M and in-licensed assets on Friday
4 months ago
Deals
China
With $120M, GSK-allied Ouro Medicines throws its hat into burgeoning TCE ring
4 months ago
Startups
Cell therapy startup A2 Biotherapeutics nets $80M Series C
4 months ago
Versant unveils Light Horse with $62M and a partnership with Novartis
4 months ago
Startups
Deals
Coave raises €32M Series A despite being two years away from the clinic
4 months ago
Startups
Aiolos team reunites with $411M for new biotech with obesity drugs from China
4 months ago
Startups
R&D
Solid Bio's former CEO launches new rare disease startup with €65M Series A
4 months ago
Startups
ARCH, F-Prime and Mubadala pump $200M into former Denali programs
4 months ago
Startups
‘Too elegant to ignore’: Novo-allied Aspect Biosystems nabs $115M for bioprinted tissue therapies
4 months ago
R&D
Exclusive: GV-backed startup Prudentia launches with $7M to help pharma make better deals, faster
4 months ago
Startups
AI
Maze files for first biotech IPO of 2025, following $115M funding boost
4 months ago
Startups
Anthem Biosciences eyes $397M public offering in India
4 months ago
Manufacturing
Exclusive: Joe Jimenez's Aditum Bio rings in new year with $428M third fund
4 months ago
Startups
European macrocycle startup Orbis raises €90M
4 months ago
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page